Düsseldorf, Germany | November 19, 2026 — Held from November 16 to 19 in Düsseldorf, MEDICA brought together medical device manufacturers, healthcare professionals, distributors, and industry leaders from around the world.
As one of the world’s premier medical trade shows, it serves as a key venue to share emerging healthcare technologies, exchange market insights and explore new collaboration opportunities.
For Vivolight Medical, MEDICA is a valuable chance to engage directly with end users and distribution partners of our vascular imaging solutions. Through on-site conversations, we gather firsthand clinical feedback, gain insights into regional market needs, and use these perspectives to guide future product development.

Upgraded V900P Takes the Spotlight Alongside Emerging Medical Technologies
At MEDICA 2026, Vivolight Medical showcased the upgraded V900P Projection Vein Finder, a near-infrared (NIR) vascular visualization device designed to help clinicians locate veins quickly and accurately.
The V900P projects a real-time map of superficial veins directly onto the patient’s skin, providing intuitive visual guidance for venipuncture and vascular access procedures. Its intelligent depth detection and precision targeting system provide additional information on vein depth and location, helping clinicians assess superficial veins and plan vascular access, particularly when veins are difficult to locate.
Building on the V800 series and feedback from healthcare professionals, the upgraded model features refined imaging algorithms and enhanced functionality for clearer real-time visualization and a more intuitive user experience, supporting efficient vascular access and first-attempt success.
We also presented the LumeaVision F100T, a point-of-care fluorescence wound imaging device designed to support comprehensive wound assessment and management. Its real-time fluorescence imaging capability helps clinicians visualize and localize bacterial fluorescence signals in and around wounds, providing additional information for assessing bacterial burden and supporting wound hygiene and treatment planning. The F100T also features automatic, non-contact digital wound measurement and enables wound images and measurements to be documented and tracked over time, supporting consistent follow-up and evaluation of wound progression. An optional thermal imaging accessory further extends its capabilities by visualizing and documenting skin temperature distribution and variations in the wound area and surrounding tissue. Together, these capabilities provide complementary information to support clinical observation and informed wound management.
Beyond vein visualization and intravascular imaging, Vivolight Medical continues to expand its vascular intervention portfolio. The FastErazer CLA-355 Cold Laser Atherectomy System uses 355 nm laser technology for peripheral vascular intervention, reflecting our continued development of technologies across diagnosis and treatment.

As MEDICA 2026 concludes, we thank everyone who visited our booth and shared insights with our team. Your feedback helps us better understand real-world clinical needs and identify opportunities for future innovation.
Vivolight Medical remains committed to developing practical, user-focused medical technologies that support healthcare professionals and contribute to better patient care.
For product information, technical documentation, or partnership inquiries, please contact our team. We look forward to continuing the conversation beyond MEDICA.
Thank you for joining us at MEDICA 2026. See you next year!
Leave A Message
Scan to WhatsApp :